Company Info

Year Established
2016

Ticker
RNAZ

Exchange
NASDAQ

Contacts

Tom Fitzgerald
Interim CEO

Daniel Vlock, M.D.
CMO

Zdravka Medarova, PhD
Founder & CSO

Company Description

TransCode Therapeutics is an RNA oncology company committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics. is an RNA oncology company committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics.